NasdaqCM - Nasdaq Real Time Price • USD
Lexaria Bioscience Corp. (LEXX)
As of 1:44 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BAXTER NICHOLAS W Director | Conversion of Exercise of derivative security | Dec 20, 2019 | 330,000 |
| BHULLAR BALJINDER Chief Financial Officer | Stock Award(Grant) | Dec 16, 2015 | 155,375 |
| BUNKA CHRISTOPHER ANDREW Chief Executive Officer | Stock Award(Grant) | Oct 13, 2022 | -- |
| DEMARTINI DAVID Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jun 8, 2011 | 3,281,250 |
| DOCHERTY JOHN MARTIN President | Stock Award(Grant) | Aug 31, 2018 | -- |
| DOWNEY GREGORY Chief Financial Officer | Stock Award(Grant) | Oct 14, 2022 | 1,954 |
| MCKECHNIE WILLIAM EDWARD Director | Conversion of Exercise of derivative security | Jul 23, 2020 | 681,476 |
| REESE ALBERT L JR Director | Stock Award(Grant) | May 24, 2022 | 16,834 |
| SPISSINGER ALLAN HORST Chief Financial Officer | Conversion of Exercise of derivative security | Feb 15, 2019 | 119,116 |
| TURKEL CATHERINE C Director | Purchase | Feb 9, 2023 | 1,500 |
Related Tickers
TERN Terns Pharmaceuticals, Inc.
4.7900
+2.13%
CLDI Calidi Biotherapeutics, Inc.
0.1620
-2.99%
PSTV Plus Therapeutics, Inc.
1.6400
+0.61%
LVTX LAVA Therapeutics N.V.
2.7800
-6.71%
PBM Psyence Biomedical Ltd.
0.8098
+6.55%
INDP Indaptus Therapeutics, Inc.
2.4399
-2.01%
LTRN Lantern Pharma Inc.
5.58
-3.31%
DSGN Design Therapeutics, Inc.
3.7150
+1.50%
PHVS Pharvaris N.V.
21.02
-1.27%
IMMP Immutep Limited
2.7300
+8.73%